` NYXH (Nyxoah SA) vs S&P 500 Comparison - Alpha Spread

NYXH
vs
S&P 500

Over the past 12 months, NYXH has underperformed S&P 500, delivering a return of -39% compared to the S&P 500's +14% growth.

Stocks Performance
NYXH vs S&P 500

Loading
NYXH
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
NYXH vs S&P 500

Performance Gap Between NYXH and GSPC
HIDDEN
Show

Performance By Year
NYXH vs S&P 500

Loading
NYXH
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Nyxoah SA vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Nyxoah SA
Glance View

Market Cap
166.7m USD
Industry
Health Care

Nyxoah SA engages in the research and development, manufacture and sale of medical devices. The company is headquartered in Mont-Saint-Guibert, Brabant-Wallon and currently employs 72 full-time employees. The company went IPO on 2020-09-18. The firm focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.

NYXH Intrinsic Value
HIDDEN
Show
Back to Top